Billion people have high blood pressure, mostly in poorer countries

The number of people with high blood pressure has almost doubled in 40 years to more than 1.1 billion worldwide, scientists have said, with the burden of the condition shifting from the rich to the poor.

In the largest study of its kind analysing blood pressure in every nation between 1975 and 2015, the scientists say it has dropped sharply in wealthy countries – possibly due to healthier diets and lifestyles – but risen in poorer ones.

The increases are especially significant in Africa and south Asia, the researchers say, and could be partly due to poor nutrition in childhood.

High blood pressure, also known as hypertension, puts extra strain on the blood vessels and major organs such as the heart, brain and kidneys. It is the world’s top cause of cardiovascular disease, which leads to strokes and heart attacks, and is estimated to cause 7.5 million deaths a year worldwide.

Led by World Health Organisation researchers working with hundreds of scientists internationally, this study covered blood pressure measurements from nearly 20 million people and was published in the Lancet medical journal.

In Europe, Britain had the lowest proportion of people with high blood pressure in 2015. South Korea, the United States and Canada had the lowest hypertension rates in the world.

More than half the world’s adults with high blood pressure in 2015 lived in Asia, the study estimates. Some 226 million people in China have high blood pressure, it says, as do 200 million in India.

“High blood pressure is no longer related to affluence – as it was in 1975 – but is now a major health issue linked with poverty,” said Majid Ezzati, a professor at Imperial College London’s school of public health.

He said that while he could not be sure why the data showed high blood pressure as more of a problem in poorer countries, it may be partly due to overall better health and more consumption of fruit and vegetables in wealthy societies.

In rich countries the condition was also caught more frequently and earlier, and managed more effectively with medicines, Ezzati said.

Blood pressure is defined by two numbers: systolic pressure, which represents the force with which the heart pumps blood into the blood vessels, and diastolic pressure, a measure of the resistance to the blood flow in the body’s blood vessels.

Both numbers are measured in millimetres of mercury (mmHg). High blood pressure is defined as 140/90 mmHg or higher.

The condition is caused by a number of factors including having a diet high in salt and low in fruit and vegetables, and not taking enough exercise.

Billion people have high blood pressure, mostly in poorer countries

Blue Cross" $65 Billion Move Away From Fee-For-Service Medicine

In the most current blow to fee-for-service medication, the nation’s Blue Cross and Blue Shield ideas say they are paying a lot more than $ 65 billion annually — about 20 % of the healthcare declare dollars they pay out — on “value-based” care that rewards greater outcomes and keeps sufferers healthier.

The moves by the nation’s 37 Blue Cross and Blue Shield organizations, a summation of which was announced right now, are the most current push away from the standard charge-for-services approach to medicine that can lead to overtreatment and unnecessary medical exams and procedures.

The Blue Cross Blue Shield Association, which is the trade group and lobby for Blue Cross plans, mentioned its member programs have a portfolio of much more than 350 “locally-created, value-based mostly programs in 49 states, Washington, D.C. and Puerto Rico.” These far more accountable contracts are with a lot more than 215,000 physicians, the association said.

The Blue Cross Blue Shield Association says the contracts with companies are taking on numerous types. They incorporate “pay for efficiency plans,” “episode-primarily based payment plans,” “patient-centered health care homes” as nicely as so-named accountable care organizations (ACOs), a rapidly emerging overall health care delivery system that rewards physicians and hospitals for doing work collectively to enhance high quality and rein in fees.

“Studies estimate that 30 cents of every single healthcare dollar goes to care that is ineffective or redundant,” Scott Serota, chief executive officer of the Blue Cross and Blue Shield Association said in a statement. “With the nation investing $ two.eight trillion on healthcare every single yr, The Blues think we need to lead in bettering care while assisting to deal with expenses.”

The Blue Cross strategies are the most recent of a parade of health insurance coverage organizations touting their moves away from charge-for-support medication as much more Americans appear for cost-effective overall health care coverage, especially the 8 million folks who purchased ideas on exchanges beneath the Reasonably priced Care Act. Blue Cross ideas are huge players on government-run exchanges below the well being law.

Blue Cross rivals like Aetna Aetna (AET), Cigna Cigna (CI), Humana Humana  (HUM) and UnitedHealth Group (UNH) are also rising the amount of worth-based contracts they have with doctors and hospitals. These insurers, which are publicly-traded, are very likely to update their efforts throughout second quarter earnings reviews over the up coming month.

UnitedHealth, for illustration, has mentioned it expects accountable care contracts to a lot more than double from $ 30 billion annually right now to $ 65 billion by the end of 2018. And Aetna has said much more than 20 percent of its health-related charges will come from value-based mostly contracts this yr.

The insurers say value-primarily based contracts are regional in nature and there is not a a single-size-fits-all approach to worth-based mostly care. Says the Blue Cross association’s Serota: “We’ll carry on to broaden locally-delivered, nationally-leveraged worth-based applications with the needs of patients in mind.”

Asking yourself how Obamacare will influence your wellness care? The Forbes eBook Inside Obamacare: The Correct For America’s Ailing Well being Care Technique answers that question and far more. Accessible now at Amazon and Apple. 

Blue Cross" $65 Billion Move Away From Fee-For-Service Medicine

How to ... get one particular billion folks to wash their hands

Standard handwashing substantially decreases diarrhoea and pneumonia – the two most significant causes of youngster death globally. Photograph: Oscar Siagian/Getty

Really shifting people’s handwashing habits at scale is less difficult mentioned than completed. At Unilever, on the Lifebuoy wellness soap group, we have embarked on a large behaviour change programme to alter the handwashing habits of one billion individuals.

The target is ambitious both in its possible to save lives – handwashing with soap is the most cost-efficient way to prevent little one deaths from diarrhoea and pneumonia (the two biggest leads to of little one death) – and in its scale.

Lifebuoy’s Assist a Kid Reach 5 handwashing programmes are based mostly on a examined methodology. A clinical trial involving 2,000 households in Mumbai demonstrated the use of soap improved by as much as ten instances right after the programmes (handwashing promotion aimed at five-12 months-olds and free soap) had been implemented. They also led to a 25% reduction in the incidences of diarrhoea among young children aged 5, 15% reduction in acute respiratory infections and 46% reduction in eye infections.

In Bonsaaso in Ghana, Unilever and the Millennium Villages Undertaking launched a partnership in 2012 to promote handwashing with soap to virtually 500,000 men and women in 80 rural villages. The preliminary evaluation showed a 22% increase in handwashing amid young children on the programme, and also a spillover into homes, with mothers and fathers of these children using 18% more soap than the manage.

Much more lately, we took the Lifebuoy campaign to Thesgora, a village in Madhya Pradesh with 1 of the highest charges of diarrhoea in India. Soon after the programme, young children in Thesgora now wash their hands on two added events per day and 33% much more mothers have commenced washing their hands with soap far more usually. Diarrhoeal charges have also fallen substantially.

So what have we learned from our experiences? Right here are a five important lessons about implementing behaviour-change programmes that perform and can be deployed expense successfully at scale.

1. Base your programme on science

Behaviour change is a science and programmes want to be built on sound outcomes – the Mumbai clinical examine is just one illustration of Lifebuoy’s collaboration with bodies like the London School of Hygiene and Tropical Medication. We use behaviour-modify theories and scientific truth and combine them with what Unilever does: communicating with customers.

2. If your audience is kids, make your material fun

Lifebuoy’s ‘School of 5′ was designed by cartoonist Craig Yoe, who has worked for MTV and Disney. This has helped to translate the science into entertaining resources for kids.

three. Make your programme worldwide, but locally related

Our programmes are created globally but need to have to work across various geographies and cultures. While we set the construction and standardise our communications, the input from regional teams is vital for programmes to be successful. For instance, although we use a key visual of an open hand welcoming school children in Pakistan, it is the signal of endorsement of the opposition celebration in one more nation, so we need to create distinct hand visuals.

4. Reach the influencers

Although the target group for us is under-fives, our capability to assist youngsters to attain 5 depends on reaching the influencers in their lives as effectively – their mothers, teachers, siblings. This is essential to ensure that handwashing behaviours are sustained.

five. Operate with partners that share your targets

We perform with a assortment of partners – Save the Youngsters, Unicef, Oxfam, Strategy, WaterAid – and governments to assist us reach exactly where the wants are the biggest. This enables us to discover from every other’s experience, share sources and, most importantly, attain more folks.

The goal of modifying 1 billion handwashing routines is a stretch, but we have the infrastructure, material and culture in area to expand numbers quickly and reach this ambitious target.

We need to have to continue creating a robust evidence base for handwashing in the publish-2015 era to make sure it stays on the agenda of national governments as a price powerful way to enhance little one survival. Publicising benefits like these from Thesgora and Bonsaaso are vital to extending the attain of these programmes, as is the continuous forging of partnerships to create and map out joint behaviour alter at scale.

Myriam Sidibe is worldwide social mission director at Unilever. Stick to @Myriam_Sidibe on Twitter.

Read far more stories like this:

• 14 methods to make sanitation sustainable

• Five memorable movements in public wellness

• The enterprise of sanitation: how partnership can plug the access gap

Join the community of worldwide advancement specialists and authorities. Become a GDPN member to get a lot more stories like this direct to your inbox

How to ... get one particular billion folks to wash their hands

How Corporate America Could Conserve $300 Billion By Measuring Overall health Like Economic Efficiency

The U.S. could save a lot more than $ 300 billion annually if employers adopted approaches that promoted well being, prevention of continual illness and measured progress of “working-age” individuals like they did their financial overall performance, according to a new report.

The examination, created by some properly-known public health advocates brought together and funded by The Vitality Institute, mentioned employers could conserve $ 217 billion to $ 303 billion annually, or five to seven percent of total U.S. yearly health spending by 2023, by adopting strategies to aid Americans head off “non-communicable” conditions like cancer, diabetes, cardiovascular and respiratory concerns as well as psychological well being.

To increase, the report’s authors say firms ought to be reporting wellness metrics like BMI and other worker well being statuses just like they frequently report earnings and how an growing quantity of companies report sustainability. Companies need to be needed to integrate well being metrics into their yearly reporting by 2025, the Vitality Institute said. A link to the whole report and its suggestions is here. 

“Companies ought to consider the wellness of their staff as 1 of their best assets,” mentioned Derek Yach, executive director of the Vitality Institute, a New York-primarily based organization funded by South Africa’s greatest overall health insurance organization, Discovery Constrained.

People involved in the report say its suggestions come at a time the Affordable Care Act and employers emphasize wellness as a way to enhance quality and reduce charges.

“Healthy staff are far more productive, resulting in improved monetary functionality,” Yach stated.  We believe this will positively influence the health of each employees and the corporate bottom line.”

The Institute brought with each other a commission linked here that consists of some executives from the wellness care sector and other people who perform in academia and enterprise. Commissioners came from Microsoft Microsoft (MSFT)  the Robert Wood Johnson Foundation drug and health-related gadget giant Johnson &amp Johnson Johnson &amp Johnson (JNJ) well being insurer Humana Humana (HUM) and the U.S. Department of Health and Humana Services.

The Vitality Institute said up to 80 % of non-communicable conditions can be prevented via existing “evidence-primarily based methods” and its report encourages the nation’s policymakers and legislative leaders to boost federal paying on prevention science at least 10 % by 2017.

“Preventable persistent ailments this kind of as lung cancer, diabetes and heart condition are forcing large numbers of people to exit the workforce prematurely due to their own bad well being or to care for sick relatives,” said William Rosenzweig, chair of the Vitality Institute Commission and an executive at Physic Ventures, which invests in health and sustainability tasks. “Yet private employers commit much less than two % of their complete overall health budgets on prevention.  This trend will stifle America’s financial growth for decades to come unless of course overall health is embraced as a core value in society.”

Asking yourself how Obamacare will affect your overall health care? The Forbes eBook Inside Obamacare: The Repair For America’s Ailing Overall health Care System answers that question and a lot more. Available now at Amazon and Apple. 

Well being (Photo credit: 401(K) 2013)

How Corporate America Could Conserve $300 Billion By Measuring Overall health Like Economic Efficiency

Why Merck Just Invested $four Billion On New Drugs For Hepatitis C

Merck announced that it is buying Idenix of Cambridge, Mass., a maker of hepatitis C drugs, for $ 3.85 billion, or $ 24.50 a share, a 238% premium over Idenix’s closing price on Thursday.  The deal is expected to close in the third quarter.

With the deal, Merck is doubling down on the ability of its own hepatitis C drugs, all still experimental, to compete with those of Gilead, which has had the most successful drug launch ever with its $ 1,000 pill, Sovaldi, this year. Sovaldi generated sales of $ 2.3 billion during its first quarter on the market, and Gilead is expected to launch a three-drug combination pill in October. Sovaldi’s price and its rapid uptake in usage have resulted in worries among insurance companies and government officials that the drug is too expensive to afford.

In an interview, Roger Perlmutter, the president of Merck Research Laboratories, said that he believes that triple drug combinations are “the future ” in hepatitis C, and that he expects to be able to reduce the duration of treatment from two months for Gilead’s treatments to as little as a month. Owning all three types of drugs needed to cure people of the virus is the fastest way to move forward.  

Hepatitis C affects as many as 170 million people worldwide and can lead to liver failure. Many Wall Street investors seem to believe that Gilead will manage to hold on to this lucrative hepatitis C market indefinitely, with competitors like Merck and AbbVie, which is bringing another hepatitis C drug combo to market, taking what’s left behind. With today’s deal, Merck is betting they are wrong. “”Let’s recognize that there are on the order of 170 million people who have hepatitis C infection,” says Perlmutter. “You’re not going to treat a substantial fraction of the world’s infections in a few years. It’s just impossible.”

Among hepatitis C acquisitions, the Idenix deal still ranks behind Gilead’s $ 11 billion purchase of Pharmasset, which gave it Sovaldi, but ahead of Bristol-Myers Squibb’s purchase of Inhibitex for $ 2.5 billion. Bristol had to halt development on Inhibitex’s lead drug after nine patients were hospitalized and one died.

Worries about toxicity have also held Idenix back. After Bristol abandoned the Inhibitex compounds, the Food and Drug Administration told Idenix to stop clinical trials of its two lead drugs, both a type of hepatitis C drug called a nucleotide polymerase inhibitor. In February, Idenix abandoned those drugs, continuing instead with the two medicines that led to Merck’s purchase of the company.

Why Merck Just Invested $four Billion On New Drugs For Hepatitis C

$1.8 Billion For The L.A. Clippers? That"s 3.27 Occasions A lot more Than Any Other NBA Team, And 120 Times The Team"s Working Revenue

Two swift ideas on the rumor that ex-Microsoft CEO Steve Ballmer is ready to pay up to $ one.8 Billion to get the Clippers.

1st, the NBA is a shared monopoly, which permits group crew owners to charge unusually large charges for the sale of their franchises as prolonged as no other crew owner is looking to promote at the exact same time.

Second, no other NBA proprietor is actively seeking to sell his staff correct now, which gives Donald Sterling a true monopoly in excess of the marketplace for buying an NBA franchise.

Based mostly on these variables, the stars purportedly have aligned for Donald Sterling to have obtained an offer you for the Clippers that is too great for even Montgomery Burns to have refused.

Presuming today’s rumors are correct, let’s put these numbers in viewpoint.

Sterling’s sale to Steve Ballmer would pay out him 3.27 times more for his franchise than the earlier NBA substantial of $ 550 million — paid for the Milwaukee Bucks back in April.  This is not a slight premium over previous NBA staff income.  It turns all previous valuations on their head.

In addition, the rumored $ 1.8 Billion sale price tag for the Clippers represents a worth of 14.06 times the team’s annual revenues and 120 times the team’s working revenue primarily based on values presented in a most recent FORBES report about NBA teams (the report that listed the Clippers’ revenues at $ 128. million and their operating earnings at $ 15. million).

This kind of ratios are astounding not only for a lot of conventional companies, but also for most sports franchise income.

Steve Ballmer. (Photo credit score: Wikipedia)

While territory rights to the Los Angeles market would on one hand appear to make the Clippers uniquely useful, the fact that the Clippers shares these NBA territory rights with the Lakers as effectively as competes to limited extent towards the NHL’s L.A. Kings would have seemed to have offset some of the market place benefits.

In addition, one would have expected the “goodwill” related with the buy of the Clippers to have been tiny if any.  Shedding methods and purportedly racist speech do not normally increase of business’s brand equity.

Prior to Sterling’s racist rant, 1 could have reasonably expected the Clippers franchise to have fetched Donald Sterling amongst $ 500 and $ 800 Million in an average sellers industry.

$ one.eight Billion?  Perhaps, V. Stiviano actually is the best salesperson of all time.

________________________________

Marc Edelman is an Associate Professor of Law at the City University of New York’s Baruch University, Zicklin School of Enterprise, where he has published a lot more than 25 law overview articles on sports activities law issues.  His latest articles or blog posts include “A Short Treatise on Amateurism and Antitrust Law” and “Are Commissioner Suspensions Actually Any Various from Illegal Group Boycotts.”

Steve Ballmer is rumored to have manufactured $ 1.8 Billion bid to get the L.A. Clippers (Photo credit: Wikipedia)

$1.8 Billion For The L.A. Clippers? That"s 3.27 Occasions A lot more Than Any Other NBA Team, And 120 Times The Team"s Working Revenue

Here is Why Elder Care May Be The Next Billion Dollar Engineering Chance

I was asked recently which industries will be most disrupted by the the Internet of Things. While no doubt all industries will be impacted long-term, I said some of the greatest alterations will be in the elder care marketplace.

Here’s why:

The value of elder care is massive

Elder care is projected to be approximately $ 319 billion in the US alone by 2016.  While this is a enormous income possibility for the incumbent elder care market, the other side of the ledger represents a enormous price for fixed-revenue seniors and their loved ones.

One of the quickest expanding segments of this industry is at-home elder care companies. While the good side of this is that the ‘at-home’ care section is portion of a broader trend in direction of aging-in-place (which relieves the burden on the elder care and assisted residing infrastructure), conventional at-residence care is still costly for each seniors, their family members and society in general.

Engineering for managing elder care is in it is infancy

We’ve come a prolonged way from the ‘I’ve fallen and I can not get up days’. Security monitoring and support technologies are enhancing rapidly, being driven by advances in bio-sensing, sensory networks, robotics, telecommunications and cloud computing.

But it is not just the enabling technologies that are getting far better. New buyer-facing engineering categories like wearables will aid in the elder care area as well. New firms like VitalConnect are establishing wearable health sensors that not only can detect body vitals like temperature and heart fee, but can also detect falls and other varieties of incidents.

Applying technology decreases costs

New technologies can carry down charges: Britain has been able to track a reduction in emergency space visits by twenty% by way of the use of a  telehealth monitor.  The FCC FCC has estimated use of body sensors decreases fees of hospital born infection by $ twelve,000 per patient.

But possibly the biggest value for families is that of live-in care.  The price for standard home care fees for live-in care – ranging anywhere from $ 300o to $ 6,000 a month – can be back breaking, and if new technologies can support reduce or hold off these expenses for a couple of many years, there is no doubt that elderly and their families will embrace them.

Increases high quality of lifestyle and autonomy

Healthcare is part of a hugely regulated and convoluted bureaucracy. By embracing preventative and dwell-in-place technologies enabled via the IoT, the elderly and their loved ones can get more control of their very own wellness and properly-getting in the long-term.

In quick, by trying to keep them out of the the healthcare and expensive caregiver market longer, they’ll have more many years and much more cash down the line.

It is Early Still

Here is Why Elder Care May Be The Next Billion Dollar Engineering Chance

Toyota"s $one.2 Billion "What Sudden Acceleration?" Settlement

The Division of Justice announced nowadays a record $ 1.2 billion settlement with Toyota in a criminal probe of its handling of sudden acceleration complaints about its vehicles. The criminal charge claims Toyota defrauded shoppers by means of misleading safety statements. Toyota Motor Corp’s deal is a record in numerous ways.

Very first, it resolves a record criminal probe of an automaker. It is the greatest monetary penalty of its kind ever imposed on an car company, said Attorney Common Eric Holder. Second, the bucks are large. Toyota will shell out a record $ one.2 billion to settle the criminal probe. Third, Toyota admitted that it misled customers about two troubles that brought on autos to accelerate although drivers have been trying to do the reverse.

crashed Toyota  (Photograph credit: Wikipedia)

Last but not least, Toyota Agreed to Forego Tax Deduction for $ one.two Billion Settlement With DOJ. Deducting the settlement would have produced taxpayers bear 35% of the price. Toyota’s road has been tortured. It at first denied that it knew about a defect leading to sudden acceleration. However, an FBI investigation unveiled inner organization documents that discussed the difficulties.

Below a deferred prosecution agreement, an independent keep track of will overview Toyota’s policies, practices and procedures. Additionally, it says ”Toyota agrees that it will not declare, assert, or apply for a tax deduction or tax credit score with regard to any federal, state, local, or foreign tax for any fine or forfeiture paid pursuant to this Agreement.” Tax deductions for organization costs are standard, given that our method taxes net income, not gross.

But some deductions rub some people the incorrect way, and this one particular is worth $ 420 million.Toyota posted a $ 5.2 billion revenue in its final quarter alone, according to the AP.  A legal settlement can frequently be deducted unless it is paid to the government and penal in nature. But since requirements are fuzzy, firms often discover a way to deduct some of all of the settlement.

In Toyota’s case, the DOJ pushed to make it clear that the company would not declare a deduction. Other latest examples of this kind of prohibitions involved Steve Cohen’s SAC Capital and JP Morgan Chase. But whether or not settlement non-deductibility ought to be explicit has turn into controversial.

The IRS has discovered that unless companies particularly prohibit it, businesses usually deduct whole settlements. A 2005 GAO report advised that companies institute clear guidelines about the tax therapy of settlements. The Truth in Settlements Act (S. 1898 – reality sheet) was launched in January. A separate bill that would restrict publish offs on settlements (S. 1654) was launched in November and has a Property counterpart (HR 3445).

U.S. PIRG’s research report, “Subsidizing Undesirable Habits: How Corporate Legal Settlements for Harming the Public Turn out to be Lucrative Tax Write-Offs. U.S. PIRG has produced a reality sheet on settlement deductions, plus truth sheets on settlement in Wall Street scandals, customer rip offs, and wellness care scams.

Tax language in settlement agreements does not bind the IRS, but it goes a long way toward avoiding tax disputes. Explicit provisions about taxes may possibly become much more typical. At the extremely least, explicit provisions impact an essential economic phrase and avoid confusion. 

Soon after all, despite punitive sounding names, some fines and penalties are viewed as remedial rather than penal in nature. That would make them deductible. That is exactly why some defendants insist that their settlement agreement confirms that the payments are not penalties and are remedial. Toyota presumably couldn’t do that right here. Certainly, the shoe was on the other foot with DOJ’s insistence on no-deduction language.

Basic Motors may possibly locate itself in a comparable place, as it is plainly following in line. GM is currently being investigated above how it dealt with an ignition switch failure linked to a several deaths. GM final month recalled far more than 1.six million automobiles 13 many years right after first noticing the concern. Every time that is resolved, it may possibly look like a Toyota knockoff.

You can reach me at Wood@WoodLLP.com. This discussion is not intended as legal guidance, and can’t be relied on for any purpose without having the providers of a certified expert.

Toyota"s $one.2 Billion "What Sudden Acceleration?" Settlement

The Market place For DNA-Sequencing-Based Down"s Syndrome Exams Could Exceed $six Billion

On Wednesday evening the New England Journal of Medication published a research showing that a new, DNA-sequencing based blood test provides a dramatic improvement in accuracy at screening for Down’s syndrome and a 2nd, connected ailment. That could open up a $ 6 billion market to the biotechnology companies that are presently advertising these exams.

Each 12 months in the U.S. there are 6.six million pregnancies and 4 million births, in accordance the Centers for Ailment Management &amp Prevention. The record costs of the exams, which are sold by four distinct organizations, assortment from $ 700 to $ 2500. Assuming that pricing settles in the middle of that range and that there are 5 million women who select to have the test, that would be a $ eight billion marketplace.

But give that number a haircut. “I have to imagine pricing could come down much more aggressively if tips expanded,” says Douglas Schenkel, an analyst at Cowen &amp Co. Not each and every pregnant woman will ever get the check. But he still argues that the industry for these exams could increase six-fold from its present dimension of about $ one billion. Isaac Ro, an analyst at Goldman Sachs, supplied comparable estimates in a note to clientele.

Such a industry expansion could be critical to all of the companies that make the tests, such as Ariosa, which can make the lowest cost check, Natera, and Sequenom Sequenom. But the biggest winner could be Illumina, the San Diego maker of DNA sequencing gear that funded the trial and that obtained Verinata, a fourth maker of the new exams, for $ 350 million final year.

Illumina says it believes Verinata has strong intellectual home position in this booming new industry. Past that, however, all four producers run their exams on Illumina’s DNA sequencing machines, which means the firm wins no matter what. Francis DeSouza, Illumina’s president, stated in an interview that, if anything at all, he expects to commit significantly less on marketing Verinata and that the business is taking care for there to be an even playing field for the exams. It prices its check in the mid-range of the marketplace, at a $ one,500 checklist price tag.

Illumina also says that it does not anticipate a value war, since the market place expansion will be dependent on healthcare societies writing suggestions that endorse the new check. Right now the American University of Obstetricians and Gynecologists suggests the DNA-based mostly tests only for mothers at substantial danger, including people more than 35.

But the NEJM paper makes a strong argument for expanding that recommendation. Proper now it is suggested that all pregnant females be presented a pair of tests – a blood test and an ultrasound to search for fluid at the base of the fetus’ neck – to display for 3 issues induced when the infant has an further copy of 1 of the 46 chromosome bundles that incorporate the human genetic code. There are 3 this kind of issues that occur commonly: trisomy 21, or Down syndrome, is the most common, creating diminished intellectual ability and slower development trisomies 18 and 13 are less typical, but are often fatal for the infant.

Present screening exams yield a huge variety of false positives, so they have to be followed up with an invasive test that samples cells from the fetus. One such check, chorionic villus sampling, has a miscarriage price of 1 in 200 the other, amniocentesis, causes miscarriages one out of every single 600 instances.

These invasive exams would nevertheless be essential to verify positives from the DNA exams, but they’d be utilised in ladies whose fetuses really do not have Down’s or other trisomies far less typically. The NEJM examine gave the old screening exams and the new DNA-based mostly test to 1,914 pregnant women and followed them right up until the baby was born. For Down Syndrome, the new test gave just six false positives compared to 69 for the previous screening exams. For trisomy 13, there had been 3 false positives with DNA sequencing in contrast to eleven with the classic number. For trisomy 13, the numbers were 1 and 6.

Assuming five million women are tested each and every year, that would indicate 245,000 would be spared an invasive check, and 358 miscarriages may possibly be prevented. Even at a larger expense, that could be tough for insurance coverage companies to say no to. Some professionals, which includes Illumina, assume that more studies will be needed to modify the recommendations.

How does the new check perform? Basically, by counting. Because some of the fetus’ cells circulate in the mother’s blood, researchers can sequence DNA and see if genes from any chromosomes appear also typically. For a much more complete description, examine out the video embedded from Steve Quake at Stanford, who co-invented Verinata’s technological innovation. His explanation commences at five:fifty five.

Not everyone is positive that the new technological innovation, recognized as non-invasive prenatal testing, is an unmixed blessing. Hank Greely, a professor of law at Stanford Law College who has written extensively on genetic concerns, says that the new test is “more reason to think NIPT will largely take more than Down’s screening.” But he warns that these very same approaches may possibly lead to exams for far more difficult tests. “If, say, 70% of American pregnancies obtained broad genetic screening, the up coming generation would look diverse – some will say for better, some for worse.”

The Market place For DNA-Sequencing-Based Down"s Syndrome Exams Could Exceed $six Billion

Massive Deal: $25 Billion Forest Sale Cements A Turnaround Artist"s Reputation

There’s a stream of internet jokes from a few years back that lauded the mythical – and impossible – achievements of martial arts star Chuck Norris. “Chuck Norris can cut via a sizzling knife with butter,” one particular mentioned. “Chuck Norris counted to infinity – twice. Chuck Norris is the reason Waldo is hiding.”

Huge pharma M&ampA just got its Chuck Norris.

I’m commencing to wonder if you could give Brent Saunders, who has now rebuilt and sold off two legendary health care brand names, just about any distressed drug firm and see it purchased a quick time later for a big, juicy premium. Practically 5 many years in the past, he took more than eye care business Bausch &amp Lomb, which had been taken personal soon after some of its goods led to deadly eye infections. “By the time we offered the business to Valiant three and a half many years later, B&ampL had the best late-stage pipeline it had ever had in its 160 many years at that point,” Saunders stated at the Forbes Healthcare Summit last 12 months. Valeant paid $ 9 billion.

Now the larger fish: 9 months ago Saunders took in excess of Forest Laboratories, the legendary drug organization that, beneath chief executive Howard Solomon in the 1990s, had pioneered a new organization model. Instead of inventing its very own medicines, Forest purchased medicines that had been laying fallow someplace else. Inspired by his son’s struggles with depression, Solomon launched two of the hottest antidepressants ever, Celexa and Lexapro, and manufactured Forest into one of the industry’s electrical power players.

Also on Forbes: When It is Time To Sell Your Organization

But patents on these drugs expired, and the patent on Namenda, a blockbuster Alzheimer’s condition therapy, would go soon. In an extra insult, U.S. officials even threatened to ban Solomon from selling to Medicare and Medicaid in connection with false claims act allegations, including that Forest had pushed Celexa on children. Carl Icahn had taken a stake in the business, and was pushing for new management.

Saunders, currently a Forest board member, took the reins and quickly received Wall Street fired up again. Saunders purchased the rights to Saphris, an antipsychotic that Saunders knew from his time at Schering-Plough, from Merck Merck for $ 240 million. He worked to create successors to Namenda, which includes a delayed release version, to sustain market share.  And he spent $ two.9 billion to get Aptalis, which tends to make drugs to ease the digestive troubles connected to cystic fibrosis and would add $ 700 million in income.

In a note to investors on January 31, Leerink pharmaceutical analyst Seamus Fernandez praised Saunders’ “tireless enthusiasm for the sector and prospects for [Forest],” crowing that an early closure of the Aptalis deal could add 5 or ten cents per share to earnings for 2014 and advised investors to buy the stock. Vamil Divan at Credit Suisse, was equally bullish, telling consumers that Forest was “in the early innings of a multi-12 months rejuvenation story.” On February four, Chris Schott, the pharmaceuticals analyst at J.P. Morgan J.P. Morgan, initiated coverage on the stock with a acquire rating, pointing in portion to Saunders’ experience at Bausch &amp Lomb and his capacity to leverage money flow to pursue much more acquistions.

This morning, Forest announced that it is getting bought by generic drug maker Aptavis for $ 25 billion. The supply involves $ 26.04 in funds and .3306 Actavis Actavis shares for every share of Forest that functions out to $ 89.48 per share for the organization, or a 105% return for traders who purchased the stock when Saunders was named as CEO on September 10 of final 12 months.

“I venture to say that as a CEO you really don’t target on promoting the organization, even if you’re personal and that’s portion of what you want to do,” Saunders said at the Forbes summit back in December. “You target on developing the strongest, ideal organization you can and if some thing comes out of left field, or by way of a method, or whatever it might be, that is the correct factor for your shareholders than you do it.”

This time it only took 9 months. Analysts who cover Forest are – huge surprise – saying that the deal need to make fiscal sense for Actavis. I believe that investors need to want to kick the tires a bit on that. Just as Chuck Norris didn’t actually do any of individuals cool issues at the best of the story, there’s a bit of myth-making concerned in firm turnarounds. Bausch really did require a great deal of work, and Saunders essential to obtain and launch merchandise. The turnaround and Forest has been more quickly and much more subtle, and it is worth pondering if swings in investor sentiment have as considerably to do with the buy price as changes in the company’s fundamental enterprise. AstraZeneca is rumored to have entertained a $ 15 billion bid surely that would have been a far better deal from the buyer’s viewpoint, even without having Saunders’ handiwork?

But the actuality is that most turnarounds are a bit of a psychological trick. That was correct, also, for Saunders’ mentor, Fred Hassan, who turned close to Pharmacia and Schering-Plough. You really do not hear doubts about Inspra, the supposed blockbuster heart drug Pfizer received with Pharmacia that then fizzled, or queries about vorapaxar, Schering’s supposedly fantastic blood thinner, attached to him a lot these days. People bear in mind the offers. And the very same will be true here.

Wall Street will bear in mind the tremendous returns Saunders delivered. That’s why he will not be out of the CEO seat for very long – and why, when he pops up once again, you must take into account acquiring the stock.

Adhere to me on Twitter @matthewherper.

Also on Forbes: Anatomy Of A Turnaround

 

Massive Deal: $25 Billion Forest Sale Cements A Turnaround Artist"s Reputation

Kicking The Habit: CVS To Quit Promoting Tobacco, Sacrificing $2 Billion In Revenue For Public Well being And Long term Growth

CVS, the biggest pharmacy chain in the United States, will stop selling cigarettes and other tobacco merchandise in all of its seven,600 shops by October one, its mother or father firm CVS Caremark CVS Caremark announced this morning. It is the first time any drugstore has ever dropped this deadly funds cow, and it is portion of a significant shift in path for the drugstore giant.

“We’ve acquired 26,000 pharmacists and nurse practitioners who are assisting hundreds of thousands of individuals each and each day,” mentioned Larry Merlo, the chief executive of CVS Caremark. “They control circumstances like substantial blood strain, higher cholesterol, and diabetes — all problems that are worsened by smoking. We’ve come to the determination that cigarettes have no place in an atmosphere exactly where healthcare is getting delivered.”

The selection acquired quick praise from the American Healthcare Association, the Robert Wood Johnson Basis, and the American Cancer Society American Cancer Society. “Over time, we think lives will be saved by this,” says Cancer Society President John Seffrin. But the public-well being-mindedness will price CVS billions – virtually. The organization says $ 2 billion in product sales will be shaved off its $ 125 billion prime line. That will strain earnings, also, even though Merlo swears incremental cost cuts will preserve individuals pressures from displaying up in its profit statements.

Merlo says that continuing to promote cigarettes, which the Surgeon Common blames for 480,000 deaths each yr from heart illness, lung cancer, and stroke, was anathema to CVS’ long-term prepare to grow to be a central player in the U.S. well being care method that interacts ever a lot more closely with patients, providing flu shots, reminding them when they are not filling prescriptions, and, via its 800 Minute Clinic in-store nurse practitioner stations, prescribing medicines. “I see my function as insuring that the firm is positioned for growth,” says Merlo. “And that is what this decision is about.”

CVS, like rivals Walgreen Walgreen and Rite-Assist Corporation, is seeing a dramatic change to its enterprise as it focuses much less on taking marginal revenue out of drug income and far more on bigger agreements with hospitals and insurance coverage firms. In fact, CVS is in the midst of an even larger shift than its competitors. Simply because of its 2007 merger with Caremark, the firm is not only a drug keep chain but also a pharmacy benefit manager, that means it performs with insurance coverage organizations and employers to control drug costs. The assumption is that by currently being a rival to each Rite-Support and positive aspects manager Express Scripts Express Scripts, CVS can extract greater cost savings and offer you better care to individuals, conserving employers money the two by cutting expenses and by generating folks healthier.

Amongst CVS’ newer offerings: a deal with insurers by means of which sufferers who have not filled a necessary prescription, like a hypertension drug, are given counseling from a pharmacist if they demonstrate up wanting something else, like an antibiotic. This is attainable since CVS has information of the two in-keep and mail-purchase prescriptions unfilled prescriptions cost the healthcare system $ 300 billion yearly, CVS says. Yet another new solution will aid sufferers indicator up for pricey medication for cancer, rheumatoid arthritis, and other “specialty” circumstances, support them figure out how to pay out for them, and permit them to both get them in the mail or select them up at a CVS story.

These new efforts have led CVS to function much more closely with hospitals, doctors’ networks, and what are referred to as Accountable Care Organizations, new kinds of organizations encouraged by Obamacare in which medical doctors agree to be paid not for every stitch, prescription, or procedure but based mostly on how nicely individuals do right after therapy. If CVS can support save money or maintain patients healthier, it may possibly get a piece of the action. But these efforts were major to cognitive dissonance, says Troyen Brennan, a former professor of medicine at Harvard Health care College who is now CVS’ chief healthcare officer.

“We would often get the question: why do you proceed to sell cigarettes?” says Brennan. “Because from the physicians’ and nurses’ stage of see, you’re either all in for healthcare or you are not.” He says he thinks that possessing been the 1st pharmacy to drop cigarettes will be a “competitive advantage” against other retail pharmacies because of the credibility it will give CVS when speaking to doctors.

It’s surely receiving good buzz from organizations pre-briefed on the announcement. Risa Lavizzo-Mourey, MD, the CEO of the Robert Wood Johnson Basis, called CVS’ cig ban “a large and crucial stage forward for moving us as a nation to a area exactly where we can be healthier.” And Robin Koval, the chief executive of Legacy, the basis formed to cease teen smoking formed when 46 states’ attorneys basic settled with tobacco makers, virtually mentioned “Wow.”

“For the number a single retail pharmacy chain to get a extremely daring stage like this and place folks and their overall health in front of revenue sends a signal that if you want to speak the speak about becoming there to serve your buyers and their healthcare demands, then you have to walk the walk,” says Koval.

In the shorter phrase, the cigarette ban might help with one particular new organization: CVS is offering patients’ smoking cessation treatment, which will usually be paid for by insurance coverage but which some individuals will require to spend for out of pocket. Sufferers will be offered numerous counseling sessions with a nurse practitioner and perhaps, if they need them, nicotine substitute gums, lozenges, or patches or medicines like Chantix and Zyban that can help sufferers quit. CVS does not promote so-called e-cigarettes, which vaporize nicotine so it can be inhaled.

Will the halo from the public health praise be sufficient to make up for the hit to earnings? Possibly. The $ 2 billion in yearly revenue lost is only one.six% of total revenue. In flip, CVS says that this will strain earnings by 17 cents per share, or 40%, on an yearly basis. But simply because the removal will not have entirely happened until October, that will only hit this year’s earnings by 6 to 9 cents per share. And CVS says it can make up individuals costs, maintaining its guidance, although that earnings coverage has to come from somewhere. The company is creating a daring bet on rebranding itself as being not just a shop, but a healthcare business. Arguably, it’s not there however. But Merlo has established a clear sense of direction, and when it comes to a massive, often slow-moving business, that is a very good thing.

Also on Forbes:

Kicking The Habit: CVS To Quit Promoting Tobacco, Sacrificing $2 Billion In Revenue For Public Well being And Long term Growth

The Billion Dollar Market Microsoft And Sony Are Ignoring

The console video game market remains large. Last September, Grand Theft Automobile 5 generated more than $ one billion in revenue in its initial couple of days, a feat even the wizards of Hogwart’s and Middle Earth by no means matched on the silver display. And the new PS4 and Xbox A single have generated tens of billions in hardware sales since their launch final fall the expensive boxes mixed for a lot more than seven million units in just the last number of months of 2013.

Not that long in the past, the rise in casual gaming on mobile units was predicted to be the downfall of game consoles. No doubt this alternate game format has had an influence, but plainly the console market place is far from dead. However, just coming out with new versions of Halo and Uncharted isn’t sufficient to allow the console makers convert massive groups of new users.

What could Sony or Microsoft deliver to the industry that truly would draw in newcomers to console gaming? One particular market they seem to be to be ignoring is cognitive enhancement, a.k.a. brain training. Neuroplasticity researchers have demonstrated that our brains are certainly malleable. We can not only discover new particular expertise, we can even improve the standard working of our brain.

To exploit this opportunity, companies like Lumosity and Posit Science have rolled out brain instruction video games. Lumosity in certain has been aggressive, raising nearly $ 70 million in funding and signing up a reported 50 million consumers across mobile and other platforms.

These aren’t the only players. Fellow Forbes contributor David DiSalvo just wrote about an energy at the University of Wisconsin, the Games+Studying+Society (GLS). They are creating video games to boost one’s potential to target – see How Video Games Will Help Us Steal Back Our Target. And, as I described in Video Game Improves Multitasking Capabilities, yet another company, Akili Interactive Labs, is doing work on video games to enhance multitasking as nicely as detect Alzheimer’s condition.

The difficulty with the current generation of brain education games is that they basically aren’t a lot entertaining. In contrast to extremely addictive video games like Candy Crush Saga (see 5 Marketing Lessons From Candy Crush Saga and immersive console video games like the Phone of Duty series, brain trainers seem much more like calisthenics. You perform them since they are supposed to be very good for you, not simply because you want to.

Maybe the greatest problem is the difference in the scale of game advancement. $ 65 million sounds like a huge amount of funds for an app developer, but a big chunk of that goes into marketing and other expense classes. And, of course, a brain instruction company has to offer you a range of video games. If any one particular game had more than a number of million dollars in improvement cost I’d be surprised.

Numbers like that search like a rounding error on the price range of a console game hit. GTA 5 reportedly cost $ 265 million to build, and titles like Tomb Raider, Disney Infinity, APB, and other individuals most likely price $ one hundred million or much more. These budgets allow armies of developers, artists, testers, and so on to create incredible experiences that individuals want to play. Not only do people buy the game, as they might a movie ticket, but they frequently turn out to be normal players logging dozens or hundreds of hrs enjoying.

Imagine if you charged the team that designed GTA five with producing a brain education game, and gave them a 9-figure spending budget – you’d have the likely to increase hundreds of thousands of brains at the identical time as the gamers engaged in what was to them exciting and even addictive perform.

Advertising and marketing, Not Technology
In a single sense, the distinction is far more advertising than technologies. Video games presently alter our brains. Study demonstrates that men and women who play action video games on a normal basis are ready to make more rapidly selections and multitask far better.

These hypothetical brain-enhancing blockbusters wouldn’t seem like the recent crop of brain-trainers. Rather, they would have to incorporate components that have been proven to yield particular cognitive advantages as element of their gameplay. This is not implausible. Today’s games usually force their gamers to do all kinds of issues – fix complex issues, deal with numerous attacking enemies, find out repetitive motions, and all types of other actions. Game gamers who would never ever pick up a book of puzzles don’t object at all when they should discover creative options to the problems that game developers place in their path.

The marketing and advertising of this kind of games would certainly have to be a balancing act. Sell a game as a brain-enhancer, and gamers will stay away from it as dull. Certainly, one particular would have to take the same method as a vitamin-enhanced soft drink. Yes, it’s the identical soft drink with the same taste you enjoy, but now it’s got healthier vitamins that you will by no means really recognize.

Still, it is unattainable to disregard the truth that far more than 50 million folks have shown at least some interest in cognitive enhancement by downloading an app or subscribing to a support. And one doesn’t have to commit $ 100 million to build a game that will play for hrs and preserve coming back – appear at Candy Crush Saga’s accomplishment. Its design and style is far, far simpler than console blockbusters but the game has proven to be addictive for a lot of hundreds of thousands of players.

Why do you believe these two worlds haven’t come together in a greater way? Is there actual potential here to build cognitive enhancers that people will crave?

Roger Dooley is the author of Brainfluence: one hundred Methods to Persuade and Persuade Customers with Neuromarketing (Wiley, 2011). Discover Roger on Twitter as @rogerdooley and at his website, Neuromarketing.

The Billion Dollar Market Microsoft And Sony Are Ignoring